NASDAQ Smallcaps Increasing In Share Value On News (DSCO, BONT, AGEN, TBET, VRML, CSIQ)
Discovery Laboratories, Inc.(NASDAQ: DSCO) announced that the United States FDA has approved SURFAXIN (lucinactant) for the prevention of Respiratory Distress Syndrome in premature infants at high risk for RDS. The stock has gone up $.78 (20.80%) bringing the intraday trade price up to $4.50 with close to 20.6mln shares exchanged. Stick around.
The Bon-Ton Stores, Inc.(NASDAQ: BONT) BONT is showing a rise in earnings as investors are pleased with the company’s performance and report. The stock has increased $1.66 (31.62%) bringing the intraday trade price up to $6.91 with close to 1.5mln shares exchanged. Can BONT continue its uptrend support for a rise in trend? Stick around.
Agenus Inc(NASDAQ: AGEN) AGEN is showing huge interest today as investors are skeptical that the company might get bought out. The stock has risen $.70 (18.72%) bringing the intraday trade price up to $4.46 with close to 817,000 shares exchanged. Can AGEN maintain its upward momentum for a rise in trend? Stick around.
Tibet Pharmaceuticals, Inc.(NASDAQ: TBET) News on TBET is that the stock may go private as investors are now buying into the stock. The stock has increased $.17 (13.29%) bringing the intraday trade price up to $1.45 with close to 2.8mln shares exchanged. Can TBET continue to rise in trend with increased support? Stick around.
Vermillion, Inc.(NASDAQ: VRML) VRML is showing some profit taking today as investors are surrendering shares due to yesterday’s gains. The stock has fallen $.83 (27.67%) bringing the intraday trade price down to $2.18 with close to 4mln shares exchanged. Can VRML recover its losses or will investors continue to sell? Stick around.
Canadian Solar Inc.(NASDAQ: CSIQ) CSIQ has maintained a bearish downtrend as investors are moving out of the stock due to lack of confidence and support. The stock has dropped $.37 (11.28%) bringing the intraday trade price down to $2.91 with close to 1.9mln shares exchanged. Can CSIQ revive its support trend? Stick around.
None of the profiles issued by TooNiceStocks.com in our daily market research blog, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. Any investor should determine whether a particular security is suitable based on the investor’s objectives, other securities holdings, financial situation needs, and tax status. This disclaimer is to be read and fully understood before using our site, or joining our opt-in newsletter services or social networks. Please note well that TooNceStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read here